Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
12726
CALL
NeuroOne Medical Technologies
NMTC
$10.3M
| $33.7K | ﹤0.01% |
+6,800
| New | +$33.9K |
2024 Q4
0 quarters
|
|
12727
PUT
Rigel Pharmaceuticals
RIGL
$861M
| $33.6K | ﹤0.01% |
2,000
-4,320
| -68% | -$82.9K |
2020 Q2
18 quarters
|
|
12728
CALL
Bar Harbor Bankshares
BHB
$654M
| $33.6K | ﹤0.01% |
+1,100
| New | +$36.4K |
2024 Q4
0 quarters
|
|
12729
PUT
Hayward Holdings
HAYW
$2.61B
| $33.6K | ﹤0.01% |
2,200
+2,000
| +1,000% | +$31.3K |
2023 Q3
5 quarters
|
|
12730
CALL
T-Rex 2X Inverse Tesla Daily Target ETF
TSLZ
$25.6M
| $33.6K | ﹤0.01% |
675
-640
| -49% | -$85.7K |
2024 Q1
3 quarters
|
|
|
CHMI
12731
PUT
Cherry Hill Mortgage Investment Corp
CHMI
$96.8M
| $33.5K | ﹤0.01% |
12,700
-5,600
| -31% | -$16.8K |
2023 Q4
4 quarters
|
|
12732
CALL
First Watch Restaurant Group
FWRG
$655M
| $33.5K | ﹤0.01% |
+1,800
| New | +$31.8K |
2024 Q4
0 quarters
|
|
12733
PUT
iShares Russell 3000 ETF
IWV
$20.6B
| $33.4K | ﹤0.01% |
+100
| New | +$33.7K |
2024 Q4
0 quarters
|
|
12734
CALL
Tiptree Inc
TIPT
$639M
| $33.4K | ﹤0.01% |
1,600
-27,300
| -94% | -$571K |
2022 Q4
8 quarters
|
|
|
CYPH
12735
CALL
Cypherpunk Technologies Inc
CYPH
$351M
| $33.4K | ﹤0.01% |
11,600
+3,100
| +36% | +$9.21K |
2021 Q4
12 quarters
|
|
12736
CALL
Sagimet Biosciences
SGMT
$621M
| $33.3K | ﹤0.01% |
7,400
+7,300
| +7,300% | +$37K |
2024 Q2
2 quarters
|
|
12737
CALL
Mine Safety
MSA
$7.04B
| $33.2K | ﹤0.01% |
200
-60,700
| -100% | -$10.4M |
2022 Q2
10 quarters
|
|
|
GOGL
12738
CALL
DELISTED
Golden Ocean Group
GOGL
| $33.2K | ﹤0.01% |
3,700
-7,900
| -68% | -$85.1K |
2021 Q2
14 quarters
|
|
12739
PUT
BARK
BARK
$73.8M
| $33.1K | ﹤0.01% |
900
-845
| -48% | -$29.6K |
2021 Q1
15 quarters
|
|
12740
CALL
Stoke Therapeutics
STOK
$1.57B
| $33.1K | ﹤0.01% |
3,000
-3,600
| -55% | -$44.2K |
2022 Q4
8 quarters
|
|
|
MOGU
12741
MOGU Inc
MOGU
$15.2M
| $33.1K | ﹤0.01% |
15,235
-2,169
| -12% | -$4.7K |
2024 Q3
1 quarter
|
|
12742
PUT
Full House Resorts
FLL
$49.8M
| $33K | ﹤0.01% |
8,100
+7,100
| +710% | +$33.5K |
2021 Q2
14 quarters
|
|
12743
CALL
VistaGen Therapeutics
VTGN
$11.1M
| $33K | ﹤0.01% |
11,200
-2,800
| -20% | -$7.88K |
2023 Q3
5 quarters
|
|
12744
CALL
ALPS Medical Breakthroughs ETF
SBIO
$197M
| $33K | ﹤0.01% |
+1,000
| New | +$37.7K |
2024 Q4
0 quarters
|
|
12745
CALL
Baytex Energy
BTE
$3.28B
| $33K | ﹤0.01% |
12,800
+12,400
| +3,100% | +$35.2K |
2023 Q2
6 quarters
|
|
12746
CALL
iRadimed
IRMD
$1.08B
| $33K | ﹤0.01% |
+600
| New | +$31.6K |
2024 Q4
0 quarters
|
|
12747
SAP
SAP
$243B
| $33K | ﹤0.01% |
134
-65,871
| -100% | -$15.7M |
2022 Q4
8 quarters
|
|
|
ENZ
12748
DELISTED
Enzo Biochem, Inc.
ENZ
| $32.8K | ﹤0.01% |
45,956
+19,362
| +73% | +$20.1K |
2024 Q3
1 quarter
|
|
|
LFT
12749
Lument Finance Trust
LFT
$26.8M
| $32.8K | ﹤0.01% |
1,271
-216
| -15% | -$5.53K |
2023 Q3
5 quarters
|
|
|
NIU
12750
CALL
Niu Technologies
NIU
$151M
| $32.8K | ﹤0.01% |
18,300
+16,700
| +1,044% | +$35.9K |
2024 Q3
1 quarter
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.